John Strouse: Grateful for ASH’s Support and for the Privilege of Working with Charity Oyedeji
John Strouse, Associate Professor of Medicine at Duke University Medical Center, shared on LinkedIn:
“I am glad that ASH exists to support researchers through this time of unprecedented disruption to research and the healthcare in the United States and that I have the privilege of working with Charity Oyedeji!”
Quoting American Society of Hematology’s post:
“This past summer, the National Institutes of Health cut funding for a sickle cell disease initiative led by Charity Oyedeji, before it was complete. The Sickle Cell Disease (SCD) Functional Assessment Validation and Refinement (SILVR) Study and the SickleFit Exercise Program were focusing on physical capabilities and independence for patients with SCD. Beyond disrupting patient care, such funding cuts may also discourage researchers, particularly those from underrepresented backgrounds, from pursuing vital work in hematology and SCD research.
Learn more and help protect critical research in hematology here.”
Get the latest ASH updates on Hemostasis Today.
-
May 26, 2026, 08:11Shady Abohashem։ Stress, Hormones, and Cardiovascular Risk in Women
-
May 26, 2026, 07:39Abdulrahman Nasiri: Managing Refractory Severe Aplastic Anemia During Pregnancy
-
May 26, 2026, 07:21Eman Badr: From Platelets to Precision Oncology
-
May 26, 2026, 07:12Jenish Christin: The Clot Buster That Buys Time in Critical Moments
-
May 26, 2026, 06:43Francisco Epelde: Cardiac Lymphatic System as an Active Regulator of Myocardial Homeostasis
-
May 26, 2026, 06:39Reza Shojaei: How Neurology is Reshaping the Plasma Market?
-
May 26, 2026, 05:4779th World Health Assembly Approves Global Equity Resolution – EHC
-
May 26, 2026, 03:02Spelile Mutupira: Process of Blood Clotting After Injury
-
May 26, 2026, 03:00Clinton Otwori: Which Blood Product Do Healthcare Workers Most Commonly Misunderstand in Practice?